290
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats

, , , &
Pages 811-823 | Published online: 11 Oct 2010

References

  • DavisMEChenZShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
  • LammersTHennikWEStormGTumor-targeted nanomedicines: principles and practiceBr J Cancer200899339239718648371
  • ShahRBKhanMANanopharmaceuticals: Challenges and regulatory perspectivede VilliersMMAramwitPKwonGSNanotechnology in Drug DeliveryNew York, NYSpringer2009621647
  • HaydenECGenomics boosts brain-cancer workNature2010463727927820090720
  • GardnerSNFernandesMCytostatic anticancer drug developmentJ Exp Ther Oncol20044191815255288
  • PapahadjopoulosDSteric stabilization. An overviewJanoffASLiposomes Rational DesignNew York, NYMarcel Dekker Inc1999112
  • SapraPTyagiPAllenTMLigand-targeted liposomes for cancer treatmentCurr Drug Deliv20052436938116305440
  • KurohaneKNambaYOkuNLiposomes modified with a synthetic Arg-Gly-Asp mimetic inhibit lung metastasis of B16BL6 melanoma cellsLife Sci200068327328111191643
  • SchiffelersRMKoningGAten HagenTLFensMHSchraaAJJanssenAPAnti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicinJ Cont Rel20039112115122
  • WillisMForssenELigand-targeted liposomesAdv Drug Deliv Rev199829324927110837594
  • AgusDBBunnPAFranklinWGarciaMOzolsRFHER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancerSemin Oncol2000276 Suppl 11S5363
  • TardiPChoiceEMasinDRedelmeierTBallyMBMaddenTDLiposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft modelsCancer Res200060133389339310910044
  • PommierYLeoEZhangHMarchandCDNA topoisomerase and their poisoning by anticancer and antibacterial drugsChem Biol201017542142320534341
  • AlagkiozidisIFacciabeneACarpenitoCIncreased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18J Transl Med2009710420003308
  • PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNature Nanotech20072751760
  • BallieAJFlorenceATHumeLRMuirheadGTRogersonAThe preparation and properties of niosomes-non-ionic surfactant vesiclesJ Pharm Pharmacol198537128638682868092
  • MukherjeeBPatraBLayekBMukherjeeASustained release of acyclovir from nano-liposomes and nano-niosomes: An in vitro studyInt J Nanomed200722213225
  • ManconiMSinicoCValentiDLoyGFaddaAMNiosomes as carriers for tretinoin. I. Preparation and propertiesInt J Pharm20022341223724811839433
  • XiangGWuJLuYLiuZLeeRJSynthesis and evaluation of a novel ligand for folate-mediated targeting liposomesInt J Pharm200835612293618242901
  • EmanuelNKedarEBolotinEMSmorodinskyNIBarenholzYTargeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing micePharm Res19961368618688792423
  • ChouhanRBajpaiAKReal time in vitro studies of doxorubicin release from PHEMA nanoparticlesJ Nanobiotechnology20097519843333
  • MukherjeeBMahapatraSGuptaRPatraBTiwariAAroraPA comparison between povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeationEur J Pharm Biopharm200559347548315760728
  • BrittainHGPhysical Characterization of Pharmaceutical SolidsNew York, NYMarcel Dekker Inc1995
  • MukherjeeBSantraKPattnaikGGhoshSPreparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymersInt J Nanomed200834487496
  • MukherjeeBRoyGGhoshSDevelopment of Denticap, a matrix based sustained release formulation for treatment of toothache, dental infection and other gum problemCurr Drug Deliv20096219920719450227
  • CabanesABriggsKEGokhalePCTreatJARahmanAComparative in vivo studies with paclitaxel and liposome encapsulated paclitaxelInt J Oncol1998125103510409538125
  • GokhalePCRadhakrishnanBHusainSRAn improved method of encapsulation of doxorubicin liposomes: pharmacological and toxicological and therapeutic evaluationBr J Cancer199674143488679456
  • CorveraEMouristenOGSingerMAZuckermannMJThe permeability and effects of acyl chain length for phospholipid bilayers containing cholesterol; theory and experimentBiochim Biophys Acta199211072612701504071
  • DadashzadehSValiAMRezaieMThe effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in ratsInt J Pharm20083531225125918082982
  • MartinFJMedical Applications of LiposomesNew York, NYElsevier Science1998
  • YuePFYuanHLYabgMPreparation, characterization and pharmacokinetic evaluation of puerarin submicron emulsionPDA J Pharm Sci Technol2008621324518402366
  • WoodleMCCollinsLRSponslerEKossovskyNPapahadjopoulosDMartinFJSterically stabilized liposomes, reduction in electrophoretic mobility but not electrostatic surface potentialBiophys J19926149029101581503
  • MatsumuraHVerbichSVDimitrovaMNSurface conductivity of counter ions on protein-adsorbed lipid liposomesPhysicochem Eng Asp200119213331336
  • DamelRAKruyffBThe function of sterols in membraneBiochim Biophys Acta19764572109132184844
  • KorsmeyerRWGurnyRDoelkerEBuriPPeppasNAMechanisms of solute release from porous hydrophilic polymersInt J Pharm19831512535
  • HixsonAWCrowellJHDependence of reaction velocity upon surface and agitationInd Eng Chem Res1931238923931